L. Hoffmann

Aarhus University Hospital

Denmark

Research Interests

Explore related searches

Professors in Medical Imaging

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (15)

Charles Mayo

University of Michigan

UNITED STATES

View details

Jasper Nijkamp

Associate Professor, Head of Innovation

Aarhus University

DENMARK

View details

Catharine Clark

Honorary Professor

University College London

UNITED KINGDOM

View details

Jacob Johansen

Aarhus University

DENMARK

View details

Mads brincker

Aalborg University

DENMARK

View details

Jesper Folsted Kallehauge

Aarhus University

DENMARK

View details

Hanna Rahbek Mortensen

Associate Professor

Aarhus University

DENMARK

View details

Eva Samsøe

Chief Medical Physicist, PhD

Zealand University Hospital Køge

DENMARK

View details

Morten Nielsen

Odense University Hospital

DENMARK

View details

Weronika Maria Szejniuk

Aalborg University

DENMARK

View details

Ditte Sloth Møller

Aarhus University

DENMARK

View details

Ane L Appelt

Associate Professor

University of Leeds

UNITED KINGDOM

View details

Martin Skovmos Nielsen

Aalborg University

DENMARK

View details

Per Rugaard Poulsen

Professor

Aarhus University

DENMARK

View details

Brita Singers Sørensen

Aarhus University

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

L. Hoffmann

Research Interests

Explore related searches

Contact this professor

Articles (20)

Recommendations for radiotherapy quality assurance in clinical trials

Electron vs proton FLASH radiation on murine skin toxicity

Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non–Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial

Reirradiation dose constraints in clinical practice: Results of an international survey

Clinical workflow for reirradiation: national consensus recommendations on imaging, treatment planning, dose accumulation, and treatment delivery

A comprehensive national audit of radiotherapy retreatment numbers, sites and indications

Radiotherapy quality assurance in the PROTECT trial – a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancer

Independent secondary dose calculation for patient‐specific quality assurance: Quantitative benefit of Monte–Carlo and custom beam modeling

Design and pre-trial dose planning quality assurance of the Nordic trial of inhomogeneous dose escalated radiotherapy for patients with limited disease small cell lung cancer

Stereotactic body radiation therapy (SBRT) of centrally located medically inoperable early-stage non-small cell lung cancer (T1-T3N0M0) − A subgroup analysis of the expanded HILUS study

Prioritizing clinical trial quality assurance for photons and protons: A failure modes and effects analysis (FMEA) comparison

Repeated deep-inspiration breath-hold CT scans at planning underestimate the actual motion between breath-holds at treatment for lung cancer and lymphoma patients

Outcome of conventional radiotherapy in small centrally located tumours or lymph nodes: minimal toxicity, remarkable survival but challenging loco-regional control

Outcome of conventional radiotherapy in small centrally located tumours or lymph nodes: minimal toxicity, remarkable survival but challenging loco-regional control

Bone versus soft-tissue setup in proton therapy for patients with oesophageal cancer

Atlas-based auto-segmentation for delineating the heart and cardiac substructures in breast cancer radiation therapy

Local control after stereotactic body radiotherapy of centrally located lung tumours

A comparison of two methods for segmentation of functional volumes in radiotherapy planning of lung cancer patients

Optimal beam angle selection and knowledge-based planning significantly reduces radiotherapy dose to organs at risk for lung cancer patients

FRoG: An independent dose and LET<inf>d</inf> prediction tool for proton therapy at ProBeam® facilities

Collaborators (15)

Charles Mayo

Jasper Nijkamp

Catharine Clark

Jacob Johansen

Mads brincker

Jesper Folsted Kallehauge

Hanna Rahbek Mortensen

Eva Samsøe

Morten Nielsen

Weronika Maria Szejniuk

Ditte Sloth Møller

Ane L Appelt

Martin Skovmos Nielsen

Per Rugaard Poulsen

Brita Singers Sørensen

Make your next move.